Bank of Montreal’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$46K Buy
12,630
+46
+0.4% +$167 ﹤0.01% 2854
2025
Q1
$24.2K Buy
+12,584
New +$24.2K ﹤0.01% 2899
2024
Q2
Sell
-68,475
Closed -$126K 3514
2024
Q1
$126K Buy
+68,475
New +$126K ﹤0.01% 2913
2021
Q2
Sell
-3,878
Closed -$12K 3513
2021
Q1
$12K Sell
3,878
-18,155
-82% -$56.2K ﹤0.01% 3861
2020
Q4
$67K Buy
22,033
+14,354
+187% +$43.6K ﹤0.01% 3330
2020
Q3
$21K Sell
7,679
-204,744
-96% -$560K ﹤0.01% 3405
2020
Q2
$2.65M Buy
212,423
+212,254
+125,594% +$2.65M ﹤0.01% 1308
2020
Q1
$1K Sell
169
-15,153
-99% -$89.7K ﹤0.01% 3618
2019
Q4
$96K Buy
15,322
+2,202
+17% +$13.8K ﹤0.01% 3004
2019
Q3
$52K Buy
13,120
+1,264
+11% +$5.01K ﹤0.01% 3120
2019
Q2
$57K Buy
11,856
+11,105
+1,479% +$53.4K ﹤0.01% 3171
2019
Q1
$6K Sell
751
-1,208
-62% -$9.65K ﹤0.01% 3576
2018
Q4
$11K Buy
1,959
+888
+83% +$4.99K ﹤0.01% 3490
2018
Q3
$9K Buy
1,071
+336
+46% +$2.82K ﹤0.01% 3616
2018
Q2
$8K Sell
735
-57,543
-99% -$626K ﹤0.01% 3667
2018
Q1
$555K Sell
58,278
-9,361
-14% -$89.1K ﹤0.01% 2011
2017
Q4
$1.01M Buy
67,639
+12,755
+23% +$190K ﹤0.01% 1777
2017
Q3
$1.08M Buy
54,884
+54,661
+24,512% +$1.07M ﹤0.01% 1800
2017
Q2
$3K Hold
223
﹤0.01% 3616
2017
Q1
$2K Hold
223
﹤0.01% 3535
2016
Q4
$2K Hold
223
﹤0.01% 3559
2016
Q3
$2K Hold
223
﹤0.01% 3572
2016
Q2
$2K Sell
223
-50
-18% -$448 ﹤0.01% 3589
2016
Q1
$2K Sell
273
-13,959
-98% -$102K ﹤0.01% 3686
2015
Q4
$184K Buy
14,232
+14,182
+28,364% +$183K ﹤0.01% 2310
2015
Q3
$0 Hold
50
﹤0.01% 3711
2015
Q2
$1K Hold
50
﹤0.01% 3573
2015
Q1
$1K Hold
50
﹤0.01% 3600
2014
Q4
$1K Buy
+50
New +$1K ﹤0.01% 3485